Benevolent Capital

About Benevolent Capital

Benevolent Capital is a family office founded in 2005 by Brett and Grant Johnson. Brett Johnson holds varying degrees of operational and ownership control over several professional soccer clubs and commercial real estate developments in the United States and United Kingdom. Grant Johnson mainly oversees Benevolent's Venture Capital and Private Equity portfolio. Since launch, the platform has grown to include an experienced group of partners, executives and investors. Its portfolio keeps growing, with investments in early-stage companies, many of which have risen in valuation since the investment, along with real estate development and professional soccer franchises. The firm describes its approach as redefining the partnership between investing and investors. As General Partners, the firm invests in every portfolio company and never takes a management fee from its LPs. It also takes no promote until or unless an investment earns a 100% preferred return (2x on invested capital), so it succeeds only when its investors succeed. Most of the current professional team at Benevolent were chief operating executives at private and public companies with over $500 Million in annual revenues before the family office was created. Their experience running successful companies, handling acquisitions, and making a wide range of debt and equity investments lets them partner with the entrepreneurs and management teams of portfolio companies, guiding growth and maximizing investor returns. Benevolent reports a proven record of successful investments with realized returns. The most notable is a $200,000 seed capital investment in Enzymatics, a biotech firm later acquired by Invitae (now owned by LabCorp Holdings Inc.), which produced over $30,000,000 in total returns.

Real estate mandate

Contacts at Benevolent Capital